
Pamicogrel
CAS No. 101001-34-7
Pamicogrel( KBT3022 )
Catalog No. M22618 CAS No. 101001-34-7
Pamicogrel is an inhibitor of COX. Pamicogrel has platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 31 | In Stock |
![]() ![]() |
5MG | 50 | In Stock |
![]() ![]() |
10MG | 80 | In Stock |
![]() ![]() |
25MG | 149 | In Stock |
![]() ![]() |
50MG | 258 | In Stock |
![]() ![]() |
100MG | 417 | In Stock |
![]() ![]() |
200MG | 601 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NamePamicogrel
-
NoteResearch use only, not for human use.
-
Brief DescriptionPamicogrel is an inhibitor of COX. Pamicogrel has platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion.
-
DescriptionPamicogrel is an inhibitor of COX. Pamicogrel has platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion. Pamicogrel also has potential in both prophylaxis and treatment of ischemic brain injury.
-
In VitroPamicogrel is a cyclooxygenase inhibitor with platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion. Pamicogrel also has potential in both prophylaxis and treatment of ischemic brain injury.
-
In Vivo——
-
SynonymsKBT3022
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number101001-34-7
-
Formula Weight448.53
-
Molecular FormulaC25H24N2O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:82 mg/mL (182.82 mM; Need ultrasonic)
-
SMILESCCOC(=O)Cn1cccc1-c1nc(c(s1)-c1ccc(OC)cc1)-c1ccc(OC)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Light P. Pamicogrel (Kanebo). IDrugs. 1999 Sep;2(9):938-42.
molnova catalog



related products
-
Sasapyrine
Salsalate is a nonsteroidal anti-inflammatory agent for oral administration. Salsalate's mode of action as an anti-inflammatory and antirheumatic agent may be due to inhibition of synthesis and release of prostaglandins.
-
FPL 62064
FPL 62064 is a potent ?dual inhibitor of 5-lipoxygenase (5-LOX) and COX (IC50 of 3.5 μM and 3.1 μM for RBL-1 cytosolic 5-lipoxygenase and prostaglandin synthetase respectively).?
-
Parecoxib
A potent and selective COX-2 inhibitor; a water-soluble prodrug of valdecoxib.